22 May 2013
Keywords: sitaliptin, ph, ii, trial, results, promising, usa-based
Article | 19 September 2005
USA-based drugmaker Merck & Co has made public the results of Phase II trials of its new investigational type-2 diabetes treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 September 2005
21 May 2013
© 2013 thepharmaletter.com